v3.26.3
Shareholders’ Equity (Tables)
 9 Months Ended
Sep. 30, 2026
Shareholders’ Equity [Abstract]  
Schedule of Preferred Share Transactions

The following table summarizes the preferred share transactions, as presented in the condensed consolidated statements of changes in shareholders’ equity:

 

    Three months ended     Nine months ended  
    September 30,     September 30,  
    2026     2025     2026     2025  
    Shares     Amount     Shares     Amount     Shares     Amount     Shares     Amount  
                                                 
Series A Preferred Share                                                
Balance at beginning of period     1,000,000     $ 11,868       -     $ -       -     $ -       -     $ -  
Sale of preferred shares     -       -       -       -       1,000,000       11,868       -       -  
Conversion into ordinary shares     (1,000,000 )     (11,868 )     -       -       (1,000,000 )     (11,868 )     -       -  
Balance at end of period     -     $ -       -     $ -       -     $ -       -     $ -  
                                                                 
Series B Preferred Share                                                                
Balance at beginning of period     1,000,000     $ 11,868       -     $ -       -     $ -       -     $ -  
Sale of preferred shares     -       -       -       -       1,000,000       11,868       -       -  
Conversion into ordinary shares     (1,000,000 )     (11,868 )     -       -       (1,000,000 )     (11,868 )     -       -  
Balance at end of period     -     $ -       -     $ -       -     $ -       -     $ -  
                                                                 
Series C Preferred Share                                                                
Balance at beginning of period     1,000,000     $ 11,868       -     $ -       -     $ -       -     $ -  
Sale of preferred shares     -       -       -       -       1,000,000       11,868       -       -  
Conversion into ordinary shares     (1,000,000 )     (11,868 )     -       -       (1,000,000 )     (11,868 )     -       -  
Balance at end of period     -     $ -       -     $ -       -     $ -       -     $ -  
                                                                 
Series D Preferred Share                                                                
Balance at beginning of period     1,000,000     $ 11,744       -     $ -       -     $ -       -     $ -  
Sale of preferred shares     -       -       -       -       1,000,000       11,744       -       -  
Conversion into ordinary shares     (124,700 )     (1,464 )     -       -       (124,700 )     (1,464 )     -       -  
Balance at end of period     875,300     $ 10,280       -     $ -       875,300     $ 10,280       -     $ -  
                                                                 
Series E Preferred Share                                                                
Balance at beginning of period     1,000,000     $ 11,744       -     $ -       -     $ -       -     $ -  
Sale of preferred shares     -       -       -       -       1,000,000       11,744       -       -  
Balance at end of period     1,000,000     $ 11,744       -     $ -       1,000,000     $ 11,744       -     $ -  
                                                                 
Total                                                                
Balance at beginning of period     5,000,000     $ 59,092       -     $ -       -     $ -       -     $ -  
Sale of preferred shares     -       -       -       -       5,000,000       59,092       -       -  
Conversion into ordinary shares     (3,124,700 )     (37,068 )     -       -       (3,124,700 )     (37,068 )     -       -  
Balance at end of period     1,875,300     $ 22,024       -     $ -       1,875,300     $ 22,024       -     $ -  
Schedule of Company Recorded Stock Option Expense the Company recorded stock option expense (recapture of expense) as follows:

 

    Three months ended     Nine months ended  
    September 30,     September 30,  
    2026     2025     2026     2025  
Stock option expense (recapture of expense)   $ 282,399     $ 228,822     $ (69,992 )   $ 1,245,295  
Schedule of Summary of Activity

A summary of stock option activity during the nine months ended September 30, 2026 is as follows:

 

    Stock     Weighted-
Average		     Weighted-
Average		  
    options
Outstanding		     Exercise
Price		     Life
(years)		  
Balance as of December 31, 2025     449,304     $ 29.50       8.86  
Grants     1,592,520       1.17       10.00  
Forfeited     (86,279 )     10.71       -  
Cancelled     (275,076 )     34.26       -  
Expired     -       -       -  
Balance as of September 30, 2026     1,680,469     $ 2.81       9.74  
                         
Exercisable as of September 30, 2026     253,089     $ 12.07       9.24  
Schedule of Summary of Activity Regarding Warrants Excluding Pre-funded Warrants

A summary of warrant activity, excluding pre-funded warrants, during the nine months ended September 30, 2026 is as follows:

 

        Weighted-
Average		     Weighted-
Average		  
    Warrants
Outstanding		     Exercise
Price		     Life
(years)		  
Balance as of December 31, 2025     8,805,020     $ 2.30       2.57  
Grants     -       -       -  
Exercised     (8,700,854 )     1.75       -  
Expired     -       -       -  
Balance as of September 30, 2026     104,166     $ 48.00       2.13  
Schedule of Stock-Option Fair Values were Estimated using the Black-Scholes Option-Pricing Model

For the nine months ended September 30, 2026, stock-option fair values were estimated using the Black-Scholes option-pricing model, with the following assumptions:

 

Exercise price   $ 1.14 - 1.37  
Expected term     5.75 years  
Expected average volatility     137 %
Expected dividend yield     0 %
Risk-free interest rate     4.39 - 4.41%